THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 119 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $203,000 | -11.4% | 9,636 | -4.5% | 0.00% | -33.3% |
| Q1 2019 | $229,000 | -59.0% | 10,088 | -27.9% | 0.01% | -14.3% |
| Q2 2017 | $558,000 | -26.3% | 13,995 | -31.9% | 0.01% | -22.2% |
| Q1 2017 | $757,000 | +76.0% | 20,558 | +52.5% | 0.01% | +125.0% |
| Q4 2016 | $430,000 | -8.7% | 13,478 | +3.7% | 0.00% | -33.3% |
| Q3 2016 | $471,000 | +84.7% | 13,001 | +15.7% | 0.01% | +100.0% |
| Q2 2016 | $255,000 | – | 11,238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |